Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018)
Siga Technologies (SIGA) reported Non-Current Deffered Revenue of $376.0 million for Q1 2018, little changed on a YoY basis from $376.2 million in Q1 2017, and little changed quarter-over-quarter from $377.6 million in Q4 2017.
Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018) Analysis & Trends
Siga Technologies has reported Non-Current Deffered Revenue for 8 years, with the latest figure at $376.0 million in Q1 2018.
- For the quarter ending Q1 2018, Non-Current Deffered Revenue changed 0.05% year-over-year to $376.0 million; the trailing twelve-month figure through Mar 2018 stood at $376.0 million (changed 0.05% YoY), and the FY2017 full-year result was $377.6 million, up 2.76% from the prior year.
- Non-Current Deffered Revenue for Q1 2018 stood at $376.0 million, roughly flat from $377.6 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $377.6 million in Q4 2017, with the low at $81799.0 in Q4 2014.
- Historically, Non-Current Deffered Revenue has averaged $268.5 million across 5 years, with a median of $271.9 million in 2016.
- Annual changes were most pronounced in 2014 — Non-Current Deffered Revenue tumbled 99.95% — and 2015, when it surged 311955.61%.
- Siga Technologies' Non-Current Deffered Revenue stood at $81799.0 in 2014, then surged by 311955.61% to $255.3 million in 2015, then surged by 43.97% to $367.5 million in 2016, then gained by 2.76% to $377.6 million in 2017, then retreated by 0.43% to $376.0 million in 2018.
- The last three Non-Current Deffered Revenue figures came in at $376.0 million (Q1 2018), $377.6 million (Q4 2017), and $377.4 million (Q3 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 376.03 Mn |
| Dec 31, 2017 | 377.64 Mn |
| Sep 30, 2017 | 377.45 Mn |
| Jun 30, 2017 | 376.48 Mn |
| Mar 31, 2017 | 376.20 Mn |
| Dec 31, 2016 | 367.48 Mn |
| Sep 30, 2016 | 367.12 Mn |
| Jun 30, 2016 | 288.29 Mn |
| Mar 31, 2016 | 255.47 Mn |
| Dec 31, 2015 | 255.26 Mn |
| Sep 30, 2015 | 255.09 Mn |
| Jun 30, 2015 | 233.74 Mn |
| Mar 31, 2015 | 13.53 Mn |
| Dec 31, 2014 | 81,799.00 |
| Jun 30, 2014 | 188.08 Mn |
| Mar 31, 2014 | 187.78 Mn |
| Dec 31, 2013 | 162.22 Mn |
| Sep 30, 2013 | 162.06 Mn |
| Jun 30, 2013 | 119.07 Mn |
| Mar 31, 2013 | 83.51 Mn |